Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
about
Cardiovascular effects of basal insulinsLimitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study.Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetesGlycemic Control Outcomes by Gender in the Pay-for-Performance System: A Retrospective Database Analysis in Patients with Type 2 Diabetes Mellitus.Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activitiesTreatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents--a randomized, prospective, crossover, open clinical trial.Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.Pharmacological treatment of type 2 diabetes.Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients.
P2860
Q26800249-8AAFCF0F-DA8B-46F4-AC57-1B6962C6808FQ33254077-C9186301-2147-41A0-A40A-0424766E92F2Q33558371-DE4880E4-D835-4B98-98BF-6CBF45CFAFE2Q34119263-B97B4CEA-B2A1-4274-9B45-2FC0B1C57AE2Q34795679-DAAF5564-48B9-413F-AA88-21054DBE04A0Q35694576-24296778-9195-4B84-BFE9-CF1D22925122Q35807316-3613FBB5-EF34-408B-9EFE-7A9F394AD1AEQ35821479-40E2C86E-1DDA-4987-B9A0-579EE0E66F02Q38107347-C6AE4706-96A5-40CD-B527-9FD33860F076Q47770450-E5576FFA-9845-4249-AC50-1EDC33B75BFAQ51482087-B1042224-978F-4156-8C34-66819ECC1358
P2860
Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Combination therapy with insul ...... with type 2 diabetes mellitus.
@ast
Combination therapy with insul ...... with type 2 diabetes mellitus.
@en
Combination therapy with insul ...... with type 2 diabetes mellitus.
@nl
type
label
Combination therapy with insul ...... with type 2 diabetes mellitus.
@ast
Combination therapy with insul ...... with type 2 diabetes mellitus.
@en
Combination therapy with insul ...... with type 2 diabetes mellitus.
@nl
prefLabel
Combination therapy with insul ...... with type 2 diabetes mellitus.
@ast
Combination therapy with insul ...... with type 2 diabetes mellitus.
@en
Combination therapy with insul ...... with type 2 diabetes mellitus.
@nl
P2860
P356
P1476
Combination therapy with insul ...... with type 2 diabetes mellitus.
@en
P2860
P304
P356
10.1002/DMRR.304
P478
18 Suppl 3
P577
2002-09-01T00:00:00Z